|
ASND
|
Ascendis Pharma A/S
|
US
|
NASDAQ
|
|
ATHX
|
Athersys, Inc.
|
US
|
NASDAQ
|
|
ATNF
|
180 Life Sciences Corp.
|
US
|
NASDAQ
|
|
BACK
|
IMAC Holdings, Inc.
|
US
|
NASDAQ
|
|
BCRX
|
BioCryst Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
BCYC
|
Bicycle Therapeutics plc
|
US
|
NASDAQ
|
|
BIOR
|
Biora Therapeutics, Inc.
|
US
|
NASDAQ
|
|
BNTX
|
BioNTech SE
|
US
|
NASDAQ
|
|
BSX
|
Boston Scientific Corporation
|
US
|
NYSE
|
|
BTTX
|
Better Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CASI
|
CASI Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
CCCC
|
C4 Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CDAK
|
Codiak BioSciences, Inc.
|
US
|
NASDAQ
|
|
CDTX
|
Cidara Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CL
|
Colgate-Palmolive Company
|
US
|
NYSE
|
|
CLVS
|
Clovis Oncology, Inc.
|
US
|
NASDAQ
|
|
CNO
|
CNO Financial Group, Inc.
|
US
|
NYSE
|
|
CODX
|
Co-Diagnostics, Inc.
|
US
|
NASDAQ
|
|
COGT
|
Cogent Biosciences, Inc.
|
US
|
NASDAQ
|
|
COLL
|
Collegium Pharmaceutical, Inc.
|
US
|
NASDAQ
|